Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ARM: Axillary Reverse Mapping, A Prospective Study

NCT00572481 is registered in ClinicalTrials.gov with University of Arkansas as lead sponsor.

NCT NCT00572481
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00572481 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ARM: Axillary Reverse Mapping, A Prospective Study
Lead sponsor
University of Arkansas
Phase
Phase 2
Overall status
Active, not recruiting
Start date
May 31, 2007
Completion date
November 30, 2027
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of the breast